Tech Company Financing Transactions
Axelyf Funding Round
Brunnur Ventures and Omega ehf participated in a $2.6 million Seed funding round for Axelyf. This VC investment round was announced on 8/29/2025.
Transaction Overview
Company Name
Announced On
8/29/2025
Transaction Type
Venture Equity
Amount
$2,600,000
Round
Seed
Investors
Brunnur Ventures (Lead Investor) (Árni Blöndal)
Proceeds Purpose
The company intends to use the funds for the development of its proprietary AXL technology, which demonstrated superior in vivo gene editing potency compared to the LP-01 benchmark currently being used in Phase 3 trials.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Brookline, MA Undisclosed
USA
Brookline, MA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Overview
Axelyf ehf, a subsidiary of Axelyf, Inc. (Boston, MA), was founded in 2022 in Iceland to develop medicines for inflammatory and autoimmune conditions. A large part of our interest is to harness the safety and long history of natural products to improve health, and innovate lipid nanotechnologies to develop safer and more effective RNA medicines.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Örn Almarsson
Browse more venture capital transactions:
Prev: 8/29/2025: Sheba Joy venture capital transaction
Next: 8/29/2025: Credit Coop venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs